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Abstract
Background: The link between host MHC (major histocompatibility complex) genotype and
malaria is largely based on correlative data with little or no experimental control of potential
confounding factors. We used an experimental mouse model to test for main effects of MHC-
haplotypes, MHC heterozygosity, and MHC × parasite clone interactions. We experimentally
infected MHC-congenic mice (F2 segregants, homo- and heterozygotes, males and females) with
one of two clones of Plasmodium chabaudi and recorded disease progression.
Results: We found that MHC haplotype and parasite clone each have a significant influence on the
course of the disease, but there was no significant host genotype by parasite genotype interaction.
We found no evidence for overdominance nor any other sort of heterozygote advantage or
disadvantage.
Conclusion: When tested under experimental conditions, variation in the MHC can significantly
influence the course of malaria. However, MHC heterozygote advantage through overdominance
or dominance of resistance cannot be assumed in the case of single-strain infections. Future studies
might focus on the interaction between MHC heterozygosity and multiple-clone infections.
Background
The link between the MHC (major histocompatibility
complex) and malaria [1,2] is a widely cited example of a
link between host genes and the course of a disease. How-
ever, for humans, such links cannot be studied under con-
trolled experimental conditions. Therefore, the
significance of the MHC for disease severity is still not
fully understood [3-12].
The mouse model offers the possibility of studying poten-
tial MHC effects both under experimental conditions and
in congenic strains, i.e. in strains that differ only in the
MHC region but are identical on the rest of the genome
[13-16]. However, even when working with MHC con-
genic strains, potential confounding effects remain. This
include, firstly, host age which may influence pathogen
susceptibility and should therefore not vary with MHC
genotype. Secondly, maternal environmental effects are
known to affect offspring size, number, and general vig-
our [17,18]. Such maternal effects could explain why
some congenic strains produce different olfactory signals
only in parental strains but not in F2 segregants [19], or
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why congenic strains sometimes differ in behavior [20].
Lastly, MHC-congenic lines may differ with respect to the
mutation load on their background genes, as there is at
least one example of different mortalities during the first
days of development before blastocyst formation (as
tested under controlled in vitro conditions in Wedekind et
al. [21]). As variation in age, maternal effects or mutation
load could interact with pathogen susceptibilities [22],
studies which aim to isolate the effects of particular loci
must use breeding designs that randomize all background
effects [22-24]. F2 segregants bred and reared under con-
trolled conditions can account for such possibly con-
founding effects [22,25-27].
We studied F2 segregants of MHC congenic strains during
experimental exposure to two clones of Plasmodium
chabaudi (such infections share many similarities to P. fal-
ciparum infections in humans [28,29]). We first addressed
the following questions: (i) Do MHC genotypes differ in
their response to malaria when tested under experimental
conditions? (ii) Is there a significant interaction between
the MHC-haplotypes and the malaria clones on disease
severity? (iii) Is there an MHC heterozygote advantage in
our example of single-clone infections?
These questions were previously addressed in mice with
segregaring H-2a and H-2b haplotypes [30]. H-2a homozy-
gotes turned out to be more susceptible to both malaria
clones than H-2b homozygotes, and H-2ab heterozygotes
did worse than expected from the average response of the
homozygotes. Here, we tested additional MHC genotypes,
H-2k, H-2ak, and H-2bk, with the same methods and the
same pathogen strains as in our previous study. This
expanded analysis allowed us to address some further
questions: (iv) In general, are the previously observed sep-
arate and combined effects of host MHC, host gender,
pathogen clone, and the time course of the disease symp-
toms repeatable when tested on other host genotypes? (v)
In particular, does the H-2a haplotype again cause higher
susceptibilties than the H-2b haplotype if combined with
another haplotype (the H-2k)? (vi) Can we add two more
examples of heterozygotes doing worse than expected
from the average response of their respective homozy-
gotes?
Results
The separate and combined effects of MHC, host gender, 
and parasite clone
We first concentrate on MHC effects in the two hetero-
zygous genotypes. The fully-factorial experimental design
allowed study of the separate and combined impact of
MHC type (H-2ak, H-2bk), host gender (two sexes), and
parasite clone ("AS" and "CW"). We tracked the time
course of the disease in daily weight measurements, and
in repeated parasitemia counts and blood cell counts. The
resulting repeated measures analyses of variances (ANO-
VAs) are summarized in Table 1 and discussed below. Var-
iation in age was minimised by synchronized breeding
and excluding one exceptionally young mouse from the
analyses. When the above ANOVA model was run on age
as dependent variable (instead of any of the disease
parameters), none of the factors are significantly linked to
age, i.e. age did not significantly vary with MHC-type, gen-
der, or pathogen clone. Body weights and blood cell den-
sities at the day of exposure or one day later were also not
significantly different between the experimental groups,
except that, as expected [30,31], males were initially heav-
ier than females (t = 11.2, p < 0.0001) and had lower
blood cell densities (t = 3.4, p = 0.002).
Consistent with previous studies [30,32,33], mean para-
sitemia rose dramatically during the first 10 days post
infection (p.i.), and minimal blood cell counts and body
weights were reached on average at day 10 and 12 p.i.,
respectively (Fig. 1). At that stage, the mice had lost on
average of 4.7% (SE = 1.0) of their initial body weight and
65.8% (SE = 1.8) of their initial red blood cells. All but
two mice survived the acute phase of the infection and
recovered as parasitemia declined over the next few days
(following UK Home Office regulations, one H-2bk male
was euthanized at day 12 p.i. and one H-2ak male at day 15
p.i.).
Hosts' MHC genotype had a strong effect on overall para-
sitemia (p = 0.002, Table 1) and the time course of para-
sitemia (p = 0.016; see also Figure 1a). The MHC also
tended to influence blood cell counts (p = 0.057) but did
not significantly affect body weight change (p = 0.79,
Table 1). The H-2ak genotype was more susceptible than
the H-2bk type (Fig. 1a, b).
The two parasite clones mainly differed in the time course
of their effects on hosts, with clone AS having its peak par-
asitemia earlier than clone CW (p = 0.003 for clone × time
term, Table 1, Fig. 1c). This corresponds with a similar
pattern in the time course of the blood cell counts (p =
0.001 for clone × time, Table 1, Fig. 1d) and a correspond-
ing change in host weight over time (p = 0.003 for clone
× time, Table 1). The two sexes varied over time in their
blood cell counts (p = 0.008, Table 1) and body weight
change (p = 0.013, Table 1), and they reacted differently
to the parasite clones (significant clone × gender, time ×
clone × gender, and MHC × clone × gender interactions,
Table 1).The two clones did not significantly differ in
overall parasitemia, blood cell counts, or weight differ-
ences (p always > 0.35, Table 1). Moreover, there was no
significant interaction between parasite clone and MHC
genotype in any of the disease symptoms (MHC × clone,
Table 1).BMC Genetics 2006, 7:55 http://www.biomedcentral.com/1471-2156/7/55
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Comparing homozygotes to heterozygotes
To the above data on H-2ak and H-2bk heterozygotes, we
added data from H-2k homozygotes, as well as data from
our previous study on H-2a, H-2b, and H-2ab mice [30]
and thus offer an overall analysis that compares the effects
of six different MHC genotypes, three of them
homozygous and three heterozygous, in nested ANOVAs
for each gender. These analyses confirm that the MHC has
a significant effect on parasitemia and blood cell counts
(p = 0.009 and 0.003, respectively, Table 2) and on the
time course of the parasitemia (p = 0.018, Table 2). How-
ever, the effects could only be observed in males. None of
the MHC effects were statistically significant if tested in
females only (Table 3).
Figure 2 gives the average (± 95% CI) disease symptoms
of all six MHC genotypes we tested. It appears that none
of the three heterozygous genotypes has lower para-
sitemia than any of their respective two homozygotes, i.e.
we find no evidence for overdominance with respect to
average parasitemia. Wedekind et al. [30] tested whether
the heterozygous H-2ab had higher parasitemia than what
could be expected from the average of the respective
homozygotes by first equalizing the sample size of the two
homozygous variants before pooling them. This was done
by randomly reducing the larger group to the size of the
smaller group. The fully-factorial repeated measure
ANOVA with the fixed factors heterozygosity, gender, and
parasite clone was then calculated, and the whole proce-
dure repeated 10 times to calculate an average F and p
value (in Wedekind et al. [30] the heterozygous H-2ab had
higher parasitemia than expected from the average of the
two homozygotes). Here we did the analogous analyses
for H-2ak, comparing them to what would be expected
from the homozygous H-2a and H-2k, and for H-2bk, com-
paring them to what would be expected from the
homozygous H-2b and H-2k. None of the 2 × 10 runs
resulted in a significant difference (H-2ak: F1,18 always <
3.0; H-2bk: F1,48 always < 2.4; p always > 0.10), i.e. we did
not find any significant heterozygote advantage or disad-
vantage when we tested the two heterozygotes H-2ak and
H-2bk.
Discussion
Most studies on the link between the MHC and a disease
are based on correlative data with no experimental control
Table 1: The effect of host MHC, parasite clone and host gender on the time course of disease symptoms.
               Parasitemia     Blood cell counts Body weight change
F d.f. P F d.f. P F d.f. P
Between subjects
Host MHC 11.1 1, 38 0.002 3.9 1, 37 0.057 0.1 1, 37 0.79
Plasmodium clone <0.1 1, 38 0.95 0.9 1, 37 0.35 0.4 1, 37 0.52
Host gender 0.4 1, 38 0.51 3.1 1, 37 0.09 <0.1 1, 37 1.0
MHC × clone 0.5 1, 38 0.50 1.5 1, 37 0.24 2.7 1, 37 0.11
MHC × gender <0.1 1, 38 0.86 0.2 1, 37 0.63 <0.1 1, 37 0.91
Clone × gender 2.9 1, 38 0.10 8.6 1, 37 0.006 0.3 1, 37 0.62
MHC × clone × gender 0.1 1, 38 0.79 3.0 1, 37 0.09 4.8 1, 37 0.036
Within subjects (repeated measurements on individual mice)
Time 79.1 5, 34 <0.0001 88.4 10, 28 <0.0001 15.8 18, 20 <0.0001
Time × MHC 3.3 5, 34 0.016 0.7 10, 28 0.74 1.0 18, 20 0.53
Time × clone 4.5 5, 34 0.003 4.3 10, 28 0.001 3.6 18, 20 0.003
Time × gender 0.2 5, 34 0.95 3.2 10, 28 0.008 2.9 18, 20 0.013
Time × MHC × clone 0.7 5, 34 0.64 2.2 10, 28 0.051 1.5 18, 20 0.19
Time × MHC × gender 0.5 5, 34 0.74 1.9 10, 28 0.09 0.6 18, 20 0.86
Time × clone × gender 1.3 5, 34 0.28 1.4 10, 28 0.22 2.3 18, 20 0.037
Time × MHC × clone × gender 1.2 5, 34 0.34 1.6 10, 28 0.16 1.5 18, 20 0.18
The experiment was designed for a fully-factorial repeated measures analysis of variance (ANOVA), incorporating the fixed effect factors "host 
MHC", "host gender", and "Plasmodium clone", with repeated measures of the following dependent variable: parasitemia (6 measurements from day 
4–14), blood cell counts (11 measurements from day 1–22), and body weight (19 measurements from day 4–22) given as differences to the weight at 
day 0. For within-subject analyses we used the multivariate F-tests. One H-2ak male had to be euthanized at day 15 and could therefore only be 
included in the analysis on parasitemia. P-values that were = 0.05 in analogous tests on other H-2 genotypes [30] are marked in bold.BMC Genetics 2006, 7:55 http://www.biomedcentral.com/1471-2156/7/55
Page 4 of 9
(page number not for citation purposes)
for possible confounding effects of, for example, back-
ground genetics or non-genetic effects [2,34-37]. In the
case of malaria, we know that the severity of the disease
can be influenced by many genetic and non-genetic fac-
tors [1-12,35,38]. To elucidate the effects of particular
MHC genotypes, it is therefore necessary to control for
confounding factors and study experimental infections in
an animal model. Here, we used an experimental design
that controls for these potentially confounding effects.
Our design allowed to test the separate and combined
effects of various host and pathogen factors on the course
of malaria in mice. We found that the MHC has a signifi-
cant effect on the course of malaria. The H-2ak genotype
was more susceptible than the H-2bk type. This finding is
consistent with the previous observation that the
homozygous H-2a genotype confers greater susceptibility
than the homozygous H-2b when tested under the same
conditions with F2s [30] and under less controlled condi-
tions with the original congenic strains [13].
The severity of a disease can be seen as the result of an
interaction between hosts and their parasites and not just
as an intrinsic characteristic of a particular parasite clone
[29,39,40]. The two parasite clones caused different dis-
ease patterns (confirming previous reports of their clone-
specific characteristics [30,41,42]), but disease severity
also depended on host characteristics: the two sexes react
differently to the parasite clones (see the significant clone
× gender interactions in Table 1). Some of these interac-
tions were significant in a previous study [30], and are
thus repeatable.
Our gender-specific analyses suggested that MHC effects
on the course of malaria may be stronger in males than in
females (Tables 2 and 3). Gender-specific virulence is
common in vertebrates [43] and could potentially lead to
more pronounced effects of host genes on pathogen sus-
ceptibility in the male sex [44,45]. However, possible gen-
der-specific effects of MHC-specific disease patterns could
not be confirmed in analyses that included gender as a fac-
tor, neither in the present study (Table 1) nor in a previ-
ous one [30], with the exception of a significant MHC ×
clone × gender effect on body weight change that was not
expected [30]. Therefore, what appears to be a gender-spe-
cific MHC-link to malaria in Tables 2 and 3 could well be
the consequence of some empty cells of the fully-factorial
The effects of MHC and parasite clone on the course of disease symptoms Figure 1
The effects of MHC and parasite clone on the course of disease symptoms. The mean parasitemia (log10-trans-
formed) and the mean blood cell number (*109)/ml blood for MHC genotypes H-2ak (open triangles) and H-2bk (closed trian-
gles), or pathogen clone AS (open diamonds) and clone CW (closed diamonds) are given over the course of the disease. Black 
symbols and lines refer to the data collected in this study on H-2ak and H-2bk mice, the green symbols and hatched lines refer to 
previously published results on homozygous H-2a and H-2b mice for comparison (Fig. 1 in [30]. See Table 1 for statistics.BMC Genetics 2006, 7:55 http://www.biomedcentral.com/1471-2156/7/55
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experimental design (that forced us to do gender-specific
analyses), combined with gender-specific characteristics
that are not linked to the MHC.
The peptide-binding motifs of MHC molecules bind only
a small fraction of all peptides [46], i.e. different MHC
molecules can be expected to bind largely to non-overlap-
ping sets of peptides. This MHC specificity may well lead
to significant parasite clone × MHC-genotype interactions
and frequency-dependent selection [47-51], but our data
could not support this. In particular, we found no signifi-
cant interaction between parasite clone and MHC geno-
type for any of the disease symptoms in either the present
study (MHC × clone, Table 1) or our previous one [30].
We suggest three mutually non-exclusive explanations for
this non-significant finding: (i) The two clones, although
clearly different in some respects, may be similar at some
of their MHC-presented peptides, such that, for a given
parasite clone, disease severity is relatively stable across
host MHC types. (ii) Our statistical power may be too low
to detect existing gene-for-gene interactions, and (iii)
time- and/or condition-dependent protein expression
may partly mask existing gene-for-gene interactions. The
latter possibility seems to be supported by a significant
three-way interaction (MHC × clone × gender on body
weight change). Moreover, there was a non-significant
tendency for blood cell counts to vary over time depend-
ing on the MHC × pathogen clone combination (p =
0.051, Table 1).
When fighting infection, MHC heterozygotes are often
expected to be superior to both their respective homozy-
gotes (i.e. exhibit overdominance) because they can
present a wider range of antigens to T lymphocytes [52].
However, single infection experiments do not support this
hypothesis [53]. In our study, too, MHC heterozygotes
did not have significantly lower parasitemias than both
the respective homozygotes. We had previously found
that the heterozygotes H-2ab did even worse than expected
from the average response of the two respective homozy-
gotes [30]. This finding could not be confirmed with the
additional genotypes we studied here: heterozygotes per-
formed neither better or worse than the homozygotes.
Taken together, it appears that MHC heterozygosity has,
Table 3: The effect of MHC type and MHC heterozygosity on the time course of disease symptoms in females.
             Parasitemia             Blood cell counts        Body weight change
F d.f. P F d.f. P F d.f. P
Between subjects
MHC type 1.5 4, 71 0.21 2.4 4, 71 0.62 0.4 4, 71 0.84
MHC heterozygosity 3.6 1, 71 0.061 0.7 1, 71 0.40 0.1 1, 71 0.69
Within subjects (repeated measurements on individual mice)
Time 61.2 5, 67 <0.0001 107.2 10, 62 <0.0001 24.2 18, 254 <0.0001
Time × heterozygosity 0.7 20, 223.2 0.84 1.0 40, 237.0 0.45 1.0 72, 214.7 0.43
Time × MHC 1.5 5, 67 0.21 1.9 10, 62 0.065 0.5 18, 54 0.9
Nested ANOVA analogous to the one presented in Table 2
Table 2: The effect of MHC type and MHC heterozygosity on the time course of disease symptoms in males.
             Parasitemia         Blood cell counts        Body weight change
F d.f. P F d.f. P F d.f. P
Between subjects
MHC type 3.7 4, 79 0.009 4.4 4, 78 0.003 0.8 4, 78 0.53
MHC heterozygosity 0.2 1, 79 0.65 0.8 1, 78 0.39 0.1 1, 78 0.82
Within subjects (repeated measurements on individual mice)
Time 121.2 5, 75 <0.0001 77.4 10, 69 <0.0001 21.7 18, 61 <0.0001
Time × MHC 1.8 20, 249.7 0.018 0.8 40, 263.5 0.77 1.0 72, 242.2 0.53
Time × heterozygosity 0.9 5, 75 0.48 1.0 10, 69 0.47 1.4 18, 61 0.15
Nested ANOVA incorporating the fixed effect factors "MHC-heterozygosity" and "MHC type" (nested in "heterozygosity"), with repeated 
measures each of the same disease symptoms as in Table 1. For within-subject analyses we used the multivariate F-tests or Wilk's lambda when a 
factor had more than two levels as in "MHC". The table combines our findings on the genotypes H-2ak, H-2bk, and H-2kk with the data of Wedekind 
et al. [30] who used exactly the same methods on the host genotypes H-2aa, H-2bb, and H-2ab. This results in six MHC genotypes, three 
homozygous ones and three heterozygous ones. The analyses are separated for males (here) and females (Table 3) because the group H-2kk was not 
represented in all experimental cells (a prerequisite for full-factorial analyses).BMC Genetics 2006, 7:55 http://www.biomedcentral.com/1471-2156/7/55
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The effects of six MHC genotypes on the average disease symptoms in males and females Figure 2
The effects of six MHC genotypes on the average disease symptoms in males and females. The figure combines 
previous results on H-2aa, H-2ab, and H-2bb mice [30] with the new observations on H-2bk, H-2kk, and H-2ak mice. The results 
(means ± 95% confidence intervals) are separated for male and female hosts and are the average per subject of 6 repeated par-
asitemia measurements from day 4–14, 11 counts of blood cell number (*109)/ml blood from day 1–22, and 19 body weight 
measurements from day 4–22 given as difference to the weight at day 0 (in g). See Tables 2 and 3 for statistics (main effects of 
MHC-type).BMC Genetics 2006, 7:55 http://www.biomedcentral.com/1471-2156/7/55
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on average, little or no effect on the course of malaria in
single-strain infections.
Conclusion
We found that variation in the MHC can have a significant
effect on the course of a Plasmodium infection. The H-2a
haplotype is more susceptible than the H-2b haplotype,
regardless of whether its combined with H-2k haplotype
or tested in homozygotes, i.e. the previous findings [30]
seem to be robust and repeatable. We could also confirm
a significant effect of MHC-types on the course of para-
sitemia (the time × MHC effect in Table 1). Nearly all of
the previously observed differences between the two par-
asite clones [30,41] could also be confirmed on the new
host genotypes used here.
We have now compared three different MHC heterozy-
gotes and their component homozygotes and found no
heterozygote advantage in experimentally controlled sin-
gle-clone infections. By contrast, under "field conditions",
MHC heterozygotes may show slower disease progression
and/or more rapid clearance of an infection than the aver-
age of homozygotes (e.g. [36,37]). MHC heterozygotes
were indeed found to be overrepresented in some human
populations [54,55], indicating a population-level advan-
tage of heterozygosity that could, however, not be con-
firmed in other studies [56], and that cannot, for itself,
explain the high degree of polymorphism of the MHC
[57]. Moreover, even if a possible heterozygote advantage
is observed in population studies, it is often unclear
whether the advantage is due to overdominance, to dom-
inance of resistance, or is explained only by the specific
allele frequencies in a host population [58]. Haplotype-
specific or allele-specific measures are therefore necessary
to explain the kind of heterozygote advantage that is
observed [53,59,60]. Our combined single-strain analyses
suggests that either (i) parasites like Plasmodium sp. have
specific characteristics (e.g. a relatively large antigen reper-
toire) that obscure any heterozygote advantages which
would be expected in other kind of infections, (ii) hetero-
zygote advantages are more frequent in multi-clone or
multi-parasite infections than in single-clone infections,
or (iii) heterozygote advantages are indeed less frequent
than expected from previous studies, and the widely
assumed and sometimes supported MHC-heterozygosity
advantage in disease susceptibility is a rule with many
exceptions.
Recent studies on pathogens with a presumably smaller
antigen repertoire (Theiler's virus and Salmonella) con-
firm that MHC heterozygote advantage cannot generally
be assumed in the case of single-clone infections (Penn et
al. 2002; McClelland et al. 2003). In the case of Plasmo-
dium, genetically variable infections are harder to clear
and sometimes more virulent than single-clone infections
[33,61], and thus may lead to different host-parasite inter-
actions. Future studies might therefore incorporate a
wider range of parasite clones, or might focus on the
effects of multi-species or multiple-clone infections where
the diversity of parasite antigens confronting the MHC
could potentially change this result.
Methods
Mouse breeding and maintenance
Mice were housed in standard conditions at 21°C and on
a 12:12 h light – dark cycle, with food provided ad libitum
(41B, Harlan, UK) and 0.05% para-aminobenzoic acid
added to their drinking water. We started with three MHC-
congenic strains of mice (the MHC type given in paranthe-
ses): C57BL/10 (H-2b), B10.A (H-2a), and B10.BR (H-2k)
obtained from B&K Universal, UK. In order to control for
potential differences in the background mutation load
and for possible differences in maternal effects, we crossed
these three strains, reared the heterozygous offspring, and
crossed them to produce the F2 generation that were used
for present the experiments.
Infections and monitoring
The two cloned P. chabaudi lines we used are denoted "AS"
and "CW" [62]. Between isolation from the field and use
in this experiment, the two lines had been blood passaged
in C57Bl/6J (H-2b) mice for 8 and 6 times, respectively.
These two clones were chosen for their relatively low
growth rate and virulence compared to other clones [41].
Each mouse was infected i.p. to 105 parasites in 0.1 ml,
prepared from donor mice by diluting blood in a calf-
serum solution, i.e. 50% heat-inactivated calf-serum, 50%
Ringer's solution (27 mM Kcl, 27 mM CaCl2, 0.15 M
NaCl), 20 units heparin/ml of mouse blood. The parasites
were obtained from one donor mouse each 6–7 days p.i.
infected with frozen aliquots of blood. We infected the
males first and the females three days later. Mean (± S.E.)
age at infection was 47.5 (SE = 0.7 days). All experimental
treatments of mice were performed in accordance with the
Animal (Scientific Procedures) Act (1986) administered
by the Home Office of the U.K. (licence no. 60/5640).
The mice were weighed to the nearest 10 mg on the day of
infection and daily from days 4 to 22 p.i. Red blood cell
densities were estimated by flow cytometry (Coulter Elec-
tronics) from a 1 : 40 000 dilution of a 2 µl sample of tail
blood into Isoton solution on day 1 p.i., and every 2 days
from day 4 to 22 p.i. Thin blood smears were made from
tail blood every 2 days from day 4–14 p.i. These smears
were stained with Giemsa. Parasitemia was determined as
the average proportion of infected red blood cells. There-
fore, the number of infected and uninfected red blood
cells were determined in at least 10 randomly picked
microscopic fields per blood smear (overall average = 124BMC Genetics 2006, 7:55 http://www.biomedcentral.com/1471-2156/7/55
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red blood cells per microscopic field; only a quarter of the
non-infected cells per field was counted if cell density was
high). Parasitemia was determined from coded slides
blindly with respect to genotype and experimental treat-
ment. One mouse did not show signs of infection (no par-
asitemia) and was therefore excluded from the analyses.
Infection was confirmed in all other mice.
Genotyping
We used allelic variation at a microsatellite locus to deter-
mine the MHC genotype of each offspring produced in
the crosses.Total genomic DNA was extracted (Amersham
Biosciences Animal Tissue extraction kit) from tail sam-
ples that had been stored in 70% ethanol. Using oligonu-
cleotide primers developed by Meagher and Potts [63] we
initially examined variation at three loci which were likely
to be sufficiently close to the MHCd locus to permit dis-
crimination of alleles. These loci were identified as 24, 34
and 148 [63]. Separately for each locus, DNA fragments
were amplified via the polymerase chain reaction (PCR)
using fluorescently labelled primers. Thermal cycling con-
ditions were 25 cycles of 94°C denaturing, 50°C anneal-
ing and 72°C extension with times of 30 seconds each. A
small quantity of each PCR reaction mixture was visual-
ised on agarose gels to verify amplification. Allelic size
variants were discriminated on an ABI 377 slab gel
sequencer and the accompanying program Genescan 3.7
and Genotyper 2.5. Polymerase chain reactions success-
fully amplified ~120 to 150 bp DNA products for each of
the loci tested. Only locus 34 proved sufficiently variable
to discriminate all three size variants (alleles).
Statistics
The experiment was designed for a fully-factorial repeated
measures analysis of variance (ANOVA), with the factors
host MHC, host gender, and parasite clone, and with
repeated measure of a dependent variable each, i.e. para-
sitemia, blood cell density and weight change. Unfortu-
nately, as the genotyping was only done after the exposure
to the pathogens, some of the pathogen clone by sex com-
binations turned out to contain no replicates for the
homozygous H-2k. We therefore used only the hetero-
zygous H-2ak  and H-2bk  mice for the full model that
includes gender and clone effects. The homozygous H-2k
mice could be included in gender-specific analyses,
assuming that the pathogen clone × MHC interaction has
no or negligible effects on disease symptoms (as was
found in [30]).
All analyses were done with JMP 5.1 [64]. As the sphericity
tests were each significant for the within-subject analyses,
we used the multivariate F-tests (when factors had only
two levels as in "gender" or "clone") or Wilk's lambda
(when a factor had more than two levels as in "MHC").
Abbreviations
MHC = major histocompatibility complex
PCR = polymerase chain reaction
Authors' contributions
CW conceived the study, designed the experiment, partic-
ipated in recording the disease symptoms and in the gen-
otyping, did the statistical analyses, and wrote the first
draft of the manuscript. MW optimized the parasitemia
determination and analysed all blood samples. TJL carried
out the molecular genetic analyses. All authors helped
drafting the manuscript and approved the final version.
Acknowledgements
We thank Lesley Stevenson and John Verth for technical assistance, A. 
Read, M. Güntert, T. Rülicke and H. Hofer for various kinds of support and/
or discussion, and three reviewers for constructive comments. The study 
was supported by the Swiss National Science Foundation.
References
1. Hill AVS, Elvin J, Willis AC, Aidoo M, Allsopp CEM, Gotch FM, Gao
XM, Takiguchi M, Greenwood BM, Townsend ARM, McMichael AJ,
Whittle HC: Molecular analysis of the association of HLA-B53
and resistance to severe malaria.  Nature 1992, 360:434-439.
2. Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Twumasi P,
Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM:
Common West African HLA antigens are associated with
protection from severe malaria.  Nature 1991, 352:595-600.
3. Stevenson MM, Riley EM: Innate immunity to malaria.  Nat Rev
Immunol 2004, 4:169-180.
4. Weatherall D, Clegg JB: Genetic variability in response to infec-
tion: malaria and after.  Genes Immun 2002, 3:331-337.
5. Plebanski M, Hill AVS: The immunology of malaria infection.
Curr Opin Immunol 2000, 12:437-441.
6. Kwiatkowski D: Genetic susceptibility to malaria getting com-
plex.  Curr Opin Genet Dev 2000, 10:320-324.
7. Jepson A, SisayJoof F, Banya W, HassanKing M, Frodsham A, Bennett
S, Hill AVS, Whittle H: Genetic linkage of mild malaria to the
major histocompatibility complex in Gambian children:
Study of affected sibling pairs.  Br Med J 1997, 315:96-97.
8. Jepson A, Banya W, SisayJoof F, HassanKing M, Nunes C, Bennett S,
Whittle H: Quantification of the relative contribution of
major histocompatibility complex (MHC) and non-MHC
genes to human immune responses to foreign antigens.  Infect
Immun 1997, 65:872-876.
9. Stirnadel HA, Beck HP, Alpers MP, Smith TA: Heritability and seg-
regation analysis of immune responses to specific malaria
antigens in Papua New Guinea.  Genet Epidemiol 1999, 17:16-34.
10. Stirnadel HA, Beck HP, Alpers MP, Smith TA: Genetic analysis of
IgG subclass responses against RESA and MSP2 of Plasmo-
dium falciparum in adults in Papua New Guinea.  Epidemiol
Infect 2000, 124:153-162.
11. Stevenson MM, Lyanga JJ, Skamene E: Murine malaria: genetic
control of resistance to Plasmodium chabaudi.  Infect Immun
1982, 38:80-88.
12. Fortin A, Stevenson MM, Gros P: Complex genetic control of
susceptibility to malaria in mice.  Genes Immun 2002, 3:177-186.
13. Wunderlich F, Mossmann H, Helwig M, Schillinger G: Resistance to
Plasmodium chabaudi in B-10 mice - influence of the H-2-
complex and testosterone.  Infect Immun 1988, 56:2400-2406.
14. Medina E, North RJ: Resistance ranking of some common
inbred mouse strains to Mycobacterium tuberculosis and
relationship to major histocompatibility complex haplotype
and Nramp1 genotype.  Immunology 1998, 93:270-274.
15. Cigel F, Batchelder J, Burns JM, Yanez D, van der Heyde H, Manning
DD, Weidanz WP: Immunity to blood-stage murine malarial
parasites is MHC class II dependent.  Immunol Lett 2003,
89:243-249.BMC Genetics 2006, 7:55 http://www.biomedcentral.com/1471-2156/7/55
Page 9 of 9
(page number not for citation purposes)
16. Bagot S, Boubou MI, Campino S, Behrschmidt C, Gorgette O, Guenet
JL, Penha-Goncalves C, Mazier D, Pied S, Cazenave PA: Susceptibil-
ity to experimental cerebral malaria induced by Plasmo-
dium berghei ANKA in inbred mouse strains recently
derived from wild stock.  Infect Immun 2002, 70:2049-2056.
17. Finn CA: Reproductive capacity and litter size in mice - effect
of age and environment.  J Reprod Fertil 1963, 6:205-&.
18. Tarin JJ, Gomez-Piquer V, Rausell F, Hermenegildo C, Cano A: Effect
of delayed breeding on the reproductive performance of
female mice.  Reprod Fertil Dev 2004, 16:373-378.
19. Carroll LS, Penn DJ, Potts WK: Discrimination of MHC-derived
odors by untrained mice is consistent with divergence in
peptide-binding region residues.  Proc Natl Acad Sci U S A 2002,
99:2187-2192.
20. Heimrich B, Schwegler H, Crusio WE, Buselmaier W: Substrain
divergence in C3h inbred mice.  Behav Genet 1988, 18:671-674.
21. Wedekind C, Chapuisat M, Macas E, Rülicke T: Non-random ferti-
lization in mice correlates with the MHC and something
else.  Heredity 1996, 77:400-409.
22. Carroll LS, Potts WK: Accumulated background variation
among H2 mutant congenic strains: elimination through
PCR-based genotyping of F-2 segregants.  J Immunol Methods
2001, 257:137-143.
23. Wolfer DP, Crusio WE, Lipp HP: Knockout mice: simple solu-
tions to the problems of genetic background and flanking
genes.  Trends Neurosci 2002, 25:336-340.
24. Wedekind C, Walker M, Portmann J, Cenni B, Müller R, Binz T:
MHC-linked susceptibility to a bacterial infection, but no
MHC- linked cryptic female choice in whitefish.  J Evol Biol
2004, 17:11-18.
25. McClelland EE, Damjanovich K, Gardner K, Groesbeck Z, Ma M, Nib-
ley M, Richardson K, Riehl K, Wilkinson M, Potts WK: Infection-
dependent heterosis in MIIC-congenic F1 mice is not due to
MHC: can we trust congenic animals?  Faseb J 2002,
16:A1071-A1072.
26. Wolfer DP, Lipp HP: Dissecting the behaviour of transgenic
mice: is it the mutation, the genetic background, or the envi-
ronment?  Exp Physiol 2000, 85:627-634.
27. Gerlai R: Gene-targeting studies of mammalian behavior: Is it
the mutation or the background genotype?  Trends Neurosci
1996, 19:177-181.
28. Cox FEG: Major models in malaria research: rodent.  In
Malaria: principles and practice of malariology Edited by: Wernsdorfer
WH and McGregor I. Edinburgh, UK, Churchill Livingstone;
1988:1053-1066. 
29. Mackinnon MJ, Read AF: Virulence in malaria: an evolutionary
viewpoint.  Philos Trans R Soc Lond Ser B-Biol Sci 2004, 359:965-986.
30. Wedekind C, Walker M, Little TJ: The course of malaria in mice:
major histocompatibility complex (MHC) effects, but no
general MHC heterozygote advantage in single-strain infec-
tions.  Genetics 2005, 170:1427-1430.
31. Suckow MA, Danneman P, Brayton C: The laboratory mouse.
London, C R C Press LLC; 2000:184. 
32. Mackinnon MJ, Read AF: The effects of host immunity on viru-
lence-transmissibility relationships in the rodent malaria
parasite Plasmodium chabaudi.  Parasitology 2003, 126:103-112.
33. De Roode JC, Read AF, Chan BHK, Mackinnon MJ: Rodent malaria
parasites suffer from the presence of conspecific clones in
three-clone Plasmodium chabaudi infections.  Parasitology
2003, 127:411-418.
34. Briles WE, Briles RW, Taffs RE, Stone HA: Resistance to a malig-
nant-lymphoma in chickens is mapped to subregion of major
histocompatibility (B) complex.  Science 1983, 219:977-979.
35. Mackinnon MJ, Gunawardena DM, Rajakaruna J, Weerasingha S,
Mendis KN, Carter R: Quantifying genetic and nongenetic con-
tributions to malarial infection in a Sri Lankan population.
Proc Natl Acad Sci U S A 2000, 97:12661-12666.
36. Thursz MR, Thomas HC, Greenwood BM, Hill AVS: Heterozygote
advantage for HLA class-II type in hepatitis B virus infection.
Nature Genet 1997, 17:11-12.
37. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert
JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ: HLA and HIV-1:
Heterozygote advantage and B*35-Cw*04 disadvantage.  Sci-
ence 1999, 283:1748-1752.
38. Jepson A, Sisay-Joof F, Banya W, Hassan-King M, Frodsham A, Bennett
S, Hill AVS, Whittle HC: Genetic linkage of mild malaria to the
major histocompatibility complex in Gambian children:
Study of affected sibling pairsX.  BMJ 1997, 315:96-97.
39. Bull JJ: Perspective - Virulence.  Evolution 1994, 48:1423-1437.
40. Ebert D: The evolution and expression of parasite virulence.
In Evolution in health and disease Edited by: Stearns SS. Oxford, Oxford
University Press; 1999:161-172. 
41. Mackinnon MJ, Read AF: Genetic relationships between parasite
virulence and transmission in the rodent malaria Plasmo-
dium chabaudi.  Evolution 1999, 53:689-703.
42. Grech K, Watt K, Read AF: Host-parasite interactions for viru-
lence and resistance in a malaria model system.  Journal of Evo-
lutionary Biology 2006, 19:1620-1630.
43. Zuk M, McKean KA: Sex differences in parasite infections: pat-
terns and processes.  International Journal for Parasitology 1996,
26:1009-1024.
44. McKean KA, Nunney L: Bateman's principle and immunity:
Phenotypically plastic reproductive strategies predict
changes in immunological sex differences.  Evolution 2005,
59:1510-1517.
45. Stoehr AM, Kokko H: Sexual dimorphism in immunocompe-
tence: what does life-history theory predict?  Behavioral Ecology
2006, 17:751-756.
46. Rammensee HG, Bachmann J, Emmerich NPN, Bachor OA, Ste-
vanovic S: SYFPEITHI: database for MHC ligands and peptide
motifs.  Immunogenetics 1999, 50:213-219.
47. Carius HJ, Little TJ, Ebert D: Genetic variation in a host-parasite
association: Potential for coevolution and frequency-
dependent selection.  Evolution 2001, 55:1136-1145.
48. Little TJ: The evolutionary significance of parasitism: do para-
site-driven genetic dynamics occur ex silico?  J Evol Biol 2002,
15:1-9.
49. Hughes AL, Nei M: Maintenance of MHC polymorphism.  Nature
1992, 355:402-403.
50. Trachtenberg E, Korber B, Sollars C, Kepler TB, Hraber PT, Hayes E,
Funkhouser R, Fugate M, Theiler J, Hsu YS, Kunstman K, Wu S, Phair
J, Erlich H, Wolinsky S: Advantage of rare HLA supertype in
HIV disease progression.  Nature Medicine 2003, 9:928-935.
51. Borghans JAM, Beltman JB, De Boer RJ: MHC polymorphism
under host-pathogen coevolution.  Immunogenetics 2004,
55:732-739.
52. Doherty PC, Zinkernagel RM: Enhanced immunological surveil-
lance in mice heterozygous at H-2 gene complex.  Nature
1975, 256:50-52.
53. Apanius V, Penn D, Slev PR, Ruff LR, Potts WK: The nature of
selection on the major histocompatibility complex.  Crit Rev
Immunol 1997, 17:179-224.
54. Hedrick PW, Thomson G: Evidence for Balancing Selection at
Hla.  Genetics 1983, 104:449-456.
55. Black FL, Hedrick PW: Strong balancing selection at HLA loci:
Evidence from segregation in South Amerindian families.
Proc Natl Acad Sci U S A 1997, 94:12452-12456.
56. Garrigan D, Hedrick PW: Perspective: Detecting adaptive
molecular polymorphism: Lessons from the MHC.  Evolution
2003, 57:1707-1722.
57. De Boer RJ, Borghans JAM, van Boven M, Kesmir C, Weissing FJ:
Heterozygote advantage fails to explain the high degree of
polymorphism of the MHC.  Immunogenetics 2004, 55:725-731.
58. Lipsitch M, Bergstrom CT, Antia R: Effect of human leukocyte
antigen heterozygosity on infectious disease outcome: The
need for allele-specific measures.  BMC Medical Genetics 2003.
59. Penn DJ, Damjanovich K, Potts WK: MHC heterozygosity confers
a selective advantage against multiple-strain infections.  Proc
Natl Acad Sci U S A 2002, 99:11260-11264.
60. McClelland EE, Penn DJ, Potts WK: Major histocompatibility
complex heterozygote superiority during coinfection.  Infect
Immun 2003, 71:2079-2086.
61. Taylor LH, Mackinnon MJ, Read AF: Virulence of mixed-clone and
single-clone infections of the rodent malaria Plasmodium
chabaudi.  Evolution 1998, 52:583-591.
62. Beale GH, Carter R, Walliker D: Genetics.  In Rodent malaria Edited
by: Killick-Kendrick R and Peters W. London, Academic Press;
1978:213-245. 
63. Meagher S, Potts WK: A microsatellite-based MHC genotyping
system for house mice (Mus domesticus).  Hereditas 1997,
127:75-82.
64. JMP   [http://www.jmp.com]